Clinical Trials
45 trialsMetformin for the Prevention of Oral Cancer in Patients With Oral Leukoplakia or Erythroplakia
University of Arizona
Metformin Hydrochloride in Preventing Oral Cancer in Patients With an Oral Premalignant Lesion
National Cancer Institute (NCI)
Low-cost Screening and Image-guided Photodynamic Therapy (PDT) of Premalignant and Malignant Oral Lesions
University of Massachusetts, Boston
PDT CALCI HOL
All India Institute of Medical Sciences
Unveiling the Protein Expression Patterns in Oral Lichen Planus and Leukoplakia Through Comparative Salivary Proteomics
Kocaeli University
Evaluation of the Chemo-preventive Effect of Combined Topical and Systemic Metformin on Oral Leukoplakia
Cairo University
Efficacy of Topical Coenzyme Q10 and Curcumin for Oral Leukoplakia Treatment
Alexandria University
Evaluation of Artificial Intelligence in Diagnosis and Risk Assessment of Oral Potentially Malignant Disorders
Ain Shams University
Pioglitazone-Metformin Combination Treatment for High Risk Oral Preneoplasia
University of Minnesota
FMS
Ohio State University
Biomarkers for Oral Cancer
National Institutes of Health Clinical Center (CC)
SYMILIS OCT
University of Palermo
Safety and Efficacy of Nivolumab in Treating Oral Proliferative Verrucous Leukoplakia
Dana-Farber Cancer Institute
Saliva and Plasma Exosomes for Oral Leukoplakia Malignant Transformation Diagnosis and Oral Cancer Prognosis Monitoring
Beijing Stomatological Hospital, Capital Medical University
Oral Potentially Malignant Disorders: Comparison Between Surgical Treatment and Wait and See Approach
University of Milan
Identification of Oral Lesions Through an Autofluorescence System
Federico II University
QQA-FPD-PMML
King Khalid University
Diagnostic Accuracy of lncRNA DQ786243 and miRNA146a in Saliva of Oral Potentially Malignant Lesions
Fayoum University
Intra and Extra Oral Inspection of Oral Mucosa
Dalarna County Council, Sweden
OL_5FU
University of California, San Francisco
Pioglitazone Hydrochloride in Preventing Head and Neck Cancer in Patients With Oral Leukoplakia
National Cancer Institute (NCI)
This Study is to Evaluate the Safety and Pharmacokinetics of SBS-101 in Patients With Oral Premalignant Lesions
Skyline Biosciences
Clinical Evaluation of the OncAlert RAPID in Subjects Presenting for Evaluation and/or Initial Biopsy; Impact on Decision-Making
Vigilant Biosciences, Inc.
Diagnostic Accuracy of Salivary Gamma-synuclein in Oral Malignant and Premalignant Lesions
Cairo University
Candida Associated Cytokines in Oral Leukoplakia
All India Institute of Medical Sciences
A Randomized Study of Sulindac in Oral Premalignant Lesions
Memorial Sloan Kettering Cancer Center
Oral Cancer Screening and Education in Hong Kong
The University of Hong Kong
Diagnostic Accuracy of Salivary DNA Integrity Index in Oral Malignant and Premalignant Lesions
Cairo University
ODIN-Q
University College, London
Malondialdehyde and Nitrous Oxide as Salivary Biomarkers for Different Oral Lesions
Beni-Suef University
Evaluation of Effect of Topical Melatonin in Treatment of Oral Leukoplakia
Postgraduate Institute of Dental Sciences Rohtak
PREDICT-OLP
University of Erlangen-Nürnberg Medical School
Comparison or Rose Bengal and Toluidine Blue Staining for Lesion Detection Efficacy
The Oxford Dental College, Hospital and Research Center, Bangalore, India
Photodynamic Therapy With Porfimer Sodium in Treating Patients With Precancerous Lesions, Cancer, or Other Disease of the Aerodigestive Tract
University of Miami
Pioglitazone for Oral Premalignant Lesions
National Cancer Institute (NCI)
Bowman-Birk Inhibitor Concentrate in Preventing Cancer in Patients With Oral Leukoplakia
National Cancer Institute (NCI)
Photodynamic Therapy Using Aminolevulinic Acid in Treating Patients With Oral Leukoplakia
National Cancer Institute (NCI)
Aspirin Mouthwash in Treating Patients With Oral Leukoplakia
National Cancer Institute (NCI)
Celecoxib in Preventing Head and Neck Cancer in Patients With Oral Leukoplakia
Fox Chase Cancer Center
Rosiglitazone Maleate in Treating Patients With Oral Leukoplakia
National Cancer Institute (NCI)
Photodynamic Therapy for Oral Leukoplakia and Erythroleukoplakia
National Taiwan University Hospital
Least Invasive Nonlinear Light Microscopy
National Taiwan University Hospital
A Phase II Trial to Assess the Effects of Green Tea in Oral Leukoplakia
Rutgers, The State University of New Jersey
Treatment and Suppression of Hairy Leukoplakia in ARC Patients With Oral Acyclovir (ACV)
NIH AIDS Clinical Trials Information Service
Dapsone 100 Mg Versus 50 as Primary Prophylaxis for Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS-Related Complex (ARC)
NIH AIDS Clinical Trials Information Service